Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new rosiglitazone clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on rosiglitazone
- Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
Status: Completed, Condition Summary: HIV Infections - Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Status: Completed, Condition Summary: Type 2 Diabetes Mellitus - Rosiglitazone in Preventing Oral Cancer in Patients With Oral Leukoplakia
Status: Completed, Condition Summary: Head and Neck Cancer; Precancerous/Nonmalignant Condition - Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
Status: Recruiting, Condition Summary: Obesity; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus - Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Status: Recruiting, Condition Summary: Nonalcoholic Steatohepatitis; Nonalcoholic Fatty Liver Disease - Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Status: Recruiting, Condition Summary: Alzheimer's Disease - Rosiglitazone in Treating Patients With Pituitary Tumors
Status: Recruiting, Condition Summary: Brain and Central Nervous System Tumors - Rosiglitazone Effect on Mitochondria and Lipoatrophy
Status: Recruiting, Condition Summary: HIV Infections - Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - Relative Effects of Physical Exercise Versus Rosiglitazone on Endothelial Function in Coronary Artery Disease (CAD) Patients With Impaired Fasting Glucose or Impaired Glucose Tolerance
Status: Completed, Condition Summary: Impaired Glucose Tolerance - Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Status: Recruiting, Condition Summary: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes - Effects of Three Drugs (Colesevelam HCl, Rosiglitazone, and Sitagliptin) on Control of Blood Glucose and Lipids (e.g., Cholesterol) Will be Examined in Patients With Type 2 Diabetes Whose Blood Glucose is Not Completed Controlled With the Diabetes Drug Metformin
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes; Hyperlipidemia - RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Status: Active, not recruiting, Condition Summary: Type II Diabetes - A Trial of Rosiglitazone for Ulcerative Colitis
Status: Completed, Condition Summary: Ulcerative Colitis; Inflammatory Bowel Disease - Rosiglitazone Versus Theophylline in Asthmatic Smokers
Status: Completed, Condition Summary: Asthma - 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Status: Completed, Condition Summary: Non-Insulin-Dependent Diabetes Mellitus - The Use of Rosiglitazone to Treat Asthma
Status: Recruiting, Condition Summary: Asthma - Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Status: Active, not recruiting, Condition Summary: Alzheimer's Disease - Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
Status: Active, not recruiting, Condition Summary: Adenocarcinoma of the Prostate; Prostate Cancer - An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 2 - Rosiglitazone Effects on Cognition for Adults in Later Life
Status: Recruiting, Condition Summary: Mild Cognitive Impairment - Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver
Status: Terminated, Condition Summary: Chronic Hepatitis C Infection; Fatty Liver - Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
Status: Completed, Condition Summary: Cutaneous T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome - A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
Status: Completed, Condition Summary: Diabetes Mellitus, Type 2 - Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
Status: Completed, Condition Summary: Falciparum Malaria - A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study
Status: Completed, Condition Summary: Diabetes Mellitus, Type 2 - AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
Status: Completed, Condition Summary: Non-Insulin-Dependent Diabetes Mellitus - BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Status: Completed, Condition Summary: Non-Insulin-Dependent Diabetes Mellitus - Rosiglitazone on Microalbuminuria in Type 2 Diabetics
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes Mellitus; Microalbuminuria - A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes Mellitus